Unicycive Therapeutics, Inc. — 10-Q Filings
14 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Unicycive Therapeutics, Inc. (UNCY), sorted by most recent first. Each row links to the full filing on EdgarLookup. Unicycive Therapeutics, Inc. has filed 14 10-Q documents with the SEC since 2019. To view all SEC filings by Unicycive Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | QUARTERLY REPORT | 0001213900-25-108600 | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-076007 | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-042943 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-097118 | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-068565 | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-042298 | May 13, 2024 | Mar 31, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-086979 | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-067230 | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-040161 | May 16, 2023 | Mar 31, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-22-071557 | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | QUARTERLY REPORT | 0001213900-22-048198 | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | QUARTERLY REPORT | 0001213900-22-025684 | May 12, 2022 | Mar 31, 2022 |
| 10-Q | QUARTERLY REPORT | 0001213900-21-058276 | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | QUARTERLY REPORT | 0001213900-21-042624 | Aug 16, 2021 | Jun 30, 2021 |